J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm

Billable / valid for submission HCPCS Release 2026Q3

Short description: Ampicillin sulbactam 1.5 gm

Version history

Release	Valid from	Valid to	Description	Billable
2026Q3	2026-07-01	current	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	yes

J0202 Injection, alemtuzumab, 1 mg
J0206 Injection, allopurinol sodium, 1 mg
J0207 Injection, amifostine, 500 mg
J0208 Injection, sodium thiosulfate (pedmark), 100 mg
J0209 Injection, sodium thiosulfate (hope), 100 mg
J0210 Injection, methyldopate hcl, up to 250 mg
J0211 Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
J0216 Injection, alfentanil hydrochloride, 500 micrograms
J0217 Injection, velmanase alfa-tycv, 1 mg
J0218 Injection, olipudase alfa-rpcp, 1 mg
J0219 Injection, avalglucosidase alfa-ngpt, 4 mg
J0220 Injection, alglucosidase alfa, 10 mg, not otherwise specified
J0221 Injection, alglucosidase alfa, (lumizyme), 10 mg
J0222 Injection, patisiran, 0.1 mg
J0223 Injection, givosiran, 0.5 mg
J0224 Injection, lumasiran, 0.5 mg
J0225 Injection, vutrisiran, 1 mg
J0248 Injection, remdesivir, 1 mg
J0256 Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg
J0257 Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg